GammaDelta Therapeutics has announced that the U.S. Food and Drug Administration has cleared the Investigational New Drug application for the Company’s allogeneic variable delta 1 (Vδ1) gamma-delta (γδ) T cell therapy,

Genomic sequencing service provider Macrogen Europe has achieved a significant upgrade to its next-generation sequencing capacity.

Flow Eighteen38 and FairJourney Biologics S.A. have announced an agreement with the Hubrecht Institute to harness the potential of FJB’s proprietary llama naïve libraries to develop antibodies to be used as research tools.

AIXIAL, the CRO of ALTEN Group, announces the acquisition of UK headquartered CMED Group by ALTEN EUROPE.

H.E.L Group has announced the appointment of Oh Chee Keat (Brice Oh) as Regional Sales Director for Asia-Pacific.

Mogrify Limited has announced the second closing of its Series A financing of $17 million USD, bringing the total raised to $33 million USD in this round. The funding will support the advancement of Mogrify’s immuno-oncology and ophthalmology programs, as well as continued platform development and the exploration of cell reprogramming for novel therapeutic applications.

Adaptate Biotherapeutics has announced that its existing investors, Abingworth and Takeda Pharmaceutical Company Limited have together made a further equity investment of $18 million.

Eppendorf has introduced a new centrifuge designed to increase efficiency in the laboratory, Centrifuge 5910 Ri.

Four additional variants have been added to Eppendorf’s line-up of Move It® adjustable tip spacing pipettes.

Eppendorf continues to follow the path of sustainability by re-designing the CryoCube F570 (all voltages). The well-known standard-sized ultra-low temperature (ULT) freezer is now completely equipped with future-proof green cooling liquids and green insulation foam as well as better performance.